1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,050 | 2,170 | 15.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.08. | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 249 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen | |
| 11.07. | Careium AB: Careium reports second quarter results 2025 | 134 | GlobeNewswire (Europe) | The second quarter in summary
Net sales decreased 11.9 percent to SEK 202.1 million (229.4)Reported net sales was negatively impacted with SEK 15.1 million by the accounting of financial leases in Sweden... ► Artikel lesen | |
| 13.06. | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 122 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| 24.04. | Careium AB: Careium reports first quarter results 2025 | 72 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 13.02. | Careium AB: Careium reports fourth quarter results 2024 | 470 | GlobeNewswire (Europe) | The Fourth Quarter in SummaryNet sales increased 14.8 percent to SEK 228.9 million (199.4)Service sales was SEK 165.9 million (154.1)Product sales was SEK 63.0 million (45.3)Gross margin increased to... ► Artikel lesen | |
| 25.10.24 | Careium AB: Careium reports third quarter results 2024 | 182 | GlobeNewswire (Europe) | The quarter in summary
Net sales amounted to SEK 201.7 million (217.3), a decrease of 7.2 percent, as sales cycles were affected by prolonged lifetime of analog (UK) and 2G/3G (SWE) networks
Service... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,860 | +0,69 % | +40 Prozent seit Jahresbeginn: Fresenius kehrt mit Milliarden-Anleihe zurück - Analysten empfehlen zum Kauf! | © Foto: Arne Dedert/dpaFresenius stärkt mit einer Milliarden-Anleihe seine Bilanz und Analysten sehen trotz Rallye weiteres Kurspotenzial für die Aktie.Der Gesundheitskonzern Fresenius ist mit einer... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 47,810 | +0,40 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| THERMO FISHER | 401,75 | -1,68 % | Dividendenbekanntmachungen (15.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2954 EUR ALLEGION PLC IE00BFRT3W74 0,51 USD 0,4345 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 63,24 | -1,03 % | Eurofins Scientific SE: Weekly Report on Share Repurchases from 08th September to 12th September 2025 | Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument ... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | UNGLAUBLICHE Sondermeldung bei Synlab Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| DAVITA | 111,30 | -1,90 % | Working Together: DaVita Celebrates Joint Efforts To Advance Kidney Health Awareness and Access to Care | NORTHAMPTON, MA / ACCESS Newswire / September 9, 2025 / Kidney disease affects an estimated 35 million Americans, with 90% unaware until it's critical. As DaVita celebrates its 25th anniversary, it... ► Artikel lesen | |
| DENTSPLY SIRONA | 11,525 | -0,13 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives | CHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced that the Company has completed the evaluation of strategic... ► Artikel lesen | |
| SMITH & NEPHEW | 16,060 | -1,05 % | Smith & Nephew Plc: Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN Bioinductive Implant | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant... ► Artikel lesen | |
| SONIC HEALTHCARE | 12,864 | -0,60 % | SONIC HEALTHCARE LIMITED: Change of Director's Interest Notice | ||
| DIASORIN | 78,28 | -1,21 % | Dividendenbekanntmachungen (21.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AFLAC INC US0010551028 0,58 USD 0,5141 EUR ARCHER DANIELS MIDLAND COMPANY US0394831020 0,51 USD 0,452 EUR ASSECO BUSINESS SOLUTIONS... ► Artikel lesen | |
| PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
| FULGENT GENETICS | 18,400 | -1,60 % | Fulgent Genetics: A Risky Bet or a Hidden Gem? | ||
| PERSPECTIVE THERAPEUTICS | 2,960 | -0,67 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma | First patient dosed with [212Pb]VMT01 3.0 mCi in combination with nivolumab[212Pb]VMT01 3.0 mCi single agent dose Cohort re-opened SEATTLE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics... ► Artikel lesen | |
| IMPLANTICA | 5,690 | -3,89 % | Implantica ramps-up production with 10,000 RefluxStop units in preparation for U.S. launch, pending FDA PMA approval | VADUZ, Liechtenstein, Sept. 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop®... ► Artikel lesen | |
| OMNICELL | 27,200 | 0,00 % | Evoke Pharma, Inc.: Evoke Pharma and EVERSANA Expand GIMOTI Access to Gastro Health and Other Large GI Practices through Omnicell Relationship |
Das Unternehmen CAREIUM AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,010 (+0,49 %) liegt der Kurs bei 2,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.